Replies to post #197412 on Biotech Values

[DewDiligence]

OCRX—qD formulation is crucial for oral oCR-002 to gain the market share as maintenance therapy. compliance is one of the biggest issues here.

I would soften your statement by saying that qD dosing is highly desirable, but it may not be crucial.

Oral OCR-002 can be combined with lactulose or Xifaxan since the mode of action is totally different, barring…dverse interaction or absorption issue.

Absolutely no one will use laculose in the chronic setting for either primary or secondary prevention of HE. Think of the consequences of doing that!